| Allergy, parasites, and the hygiene hypothesis M Yazdanbakhsh, PG Kremsner, R Van Ree Science 296 (5567), 490-494, 2002 | 2069 | 2002 |
| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts The Lancet 386 (9988), 31-45, 2015 | 1553* | 2015 |
| First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children RTS, S Clinical Trials Partnership New England Journal of Medicine 365 (20), 1863-1875, 2011 | 1016 | 2011 |
| Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10 AHJ van den Biggelaar, R van Ree, LC Rodrigues, B Lell, AM Deelder, ... The Lancet 356 (9243), 1723-1727, 2000 | 919 | 2000 |
| A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants U D'Alessandro | 895* | 2012 |
| Swarm learning for decentralized and confidential clinical machine learning S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ... Nature 594 (7862), 265-270, 2021 | 756 | 2021 |
| Artesunate combinations for treatment of malaria: meta-analysis International Artemisinin Study Group The Lancet 363 (9402), 9-17, 2004 | 729 | 2004 |
| A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms D Ménard, N Khim, J Beghain, AA Adegnika, M Shafiul-Alam, O Amodu, ... New England Journal of Medicine 374 (25), 2453-2464, 2016 | 595 | 2016 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 517 | 2016 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 467 | 2015 |
| Sterile protection against human malaria by chemoattenuated PfSPZ vaccine B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ... Nature 542 (7642), 445-449, 2017 | 466 | 2017 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. RTS. S Clinical Trials Partnership PLoS medicine 11 (7), e1001685, 2014 | 466 | 2014 |
| Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren AHJ van den Biggelaar, LC Rodrigues, R van Ree, JS van der Zee, ... Journal of Infectious Diseases 189 (5), 892-900, 2004 | 466 | 2004 |
| Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial M Adjuik, P Agnamey, A Babiker, S Borrmann, P Brasseur, M Cisse, ... The Lancet 359 (9315), 1365-1372, 2002 | 409 | 2002 |
| Antimalarial combinations PG Kremsner, S Krishna The Lancet 364 (9430), 285-294, 2004 | 400 | 2004 |
| Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ... The Lancet infectious diseases 15 (12), 1450-1458, 2015 | 396 | 2015 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021 | 375 | 2021 |
| Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children AJF Luty, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, B Greve, ... The Journal of infectious diseases 179 (4), 980-988, 1999 | 338 | 1999 |
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, M ... Lancet Infectious Diseases 15 (10), 1156-1166, 2015 | 330 | 2015 |
| Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria AJF Luty, DJ Perkins, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, ... Infection and immunity 68 (7), 3909-3915, 2000 | 327 | 2000 |
Bertrand LellCenter de Recherches Medicales de LambareneПодтвержден адрес электронной почты в домене cermel.org
